These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1484311)

  • 1. High-dose ifosfamide and mesna therapy in the outpatient setting.
    Heinzman K
    J Intraven Nurs; 1992; 15(6):322-6. PubMed ID: 1484311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose ifosfamide with mesna and granulocyte-colony-stimulating factor (recombinant human G-CSF) in patients with unresectable malignant mesothelioma.
    Talbot SM; Rankin C; Taub RN; Balcerzak SP; Bhoopalam N; Chapman RA; Baker LH; Middleman EL; Antman KH
    Cancer; 2003 Jul; 98(2):331-6. PubMed ID: 12872353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I study of prolonged ambulatory infusion of Ifosfamide with oral mesna.
    Olver I; Keefe D; Myers M; Caruso D
    Chemotherapy; 2005 May; 51(2-3):142-6. PubMed ID: 15886474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous subcutaneous administration of mesna to prevent ifosfamide-induced hemorrhagic cystitis.
    Markman M; Kennedy A; Webster K; Kulp B; Peterson G; Belinson J
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):97-8. PubMed ID: 8677458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I trial of a 24-h continuous infusion of ifosfamide/mesna in acute lymphoblastic leukemia.
    Otero JC; Solidoro A; Casanova L; Vallejos C; Rodriguez W
    J Exp Ther Oncol; 1996 Mar; 1(2):84-7. PubMed ID: 9414391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of mesna with ifosfamide.
    Goren MP
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):91-6. PubMed ID: 8677457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide and mesna.
    Schoenike SE; Dana WJ
    Clin Pharm; 1990 Mar; 9(3):179-91. PubMed ID: 2107997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of ifosfamide and mesna in nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; DiSaia PJ; McGuire WP
    Gynecol Oncol; 1993 Apr; 49(1):48-50. PubMed ID: 8482560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full-dose ifosfamide can be safely administered to outpatients.
    Meazza C; Bisogno G; Casanova M; Zanetti I; Carli M; Ferrari A
    Pediatr Blood Cancer; 2008 Feb; 50(2):375-8. PubMed ID: 16847930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
    Kushner DM; Webster KD; Belinson JL; Rybicki LA; Kennedy AW; Markman M
    Gynecol Oncol; 2000 Aug; 78(2):221-7. PubMed ID: 10926807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of metastatic renal cancer with ifosfamide and mesnum with and without irradiation.
    Fosså SD; Talle K
    Cancer Treat Rep; 1980; 64(10-11):1103-8. PubMed ID: 6780190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
    Pratt CB
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epileptic seizures and treatment with ifosfamide-mesna].
    Somma-Mauvais H; Farisse P; Viallat JR
    Rev Neurol (Paris); 1994; 150(4):307-8. PubMed ID: 7863185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nursing implications in the administration of ifosfamide and mesna.
    Richters JE
    Oncol Nurs Forum; 1990; 17(2):276. PubMed ID: 2107534
    [No Abstract]   [Full Text] [Related]  

  • 15. High dose ifosfamide with mesna uroprotection.
    Cerny T
    Pathol Biol (Paris); 1993 Jan; 41(1):102. PubMed ID: 8316441
    [No Abstract]   [Full Text] [Related]  

  • 16. A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium.
    Sutton GP; Blessing JA; DeMars LR; Moore D; Burke TW; Grendys EC
    Gynecol Oncol; 1996 Oct; 63(1):25-7. PubMed ID: 8898163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide in the treatment of soft tissue sarcomas.
    Connelly EF; Budd GT
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of ifosfamide and mesna in previously treated patients with non-Hodgkin's lymphoma: Cancer and Leukemia Group B study 8552.
    Case DC; Anderson J; Ervin TJ; Gottlieb A
    Hematol Oncol; 1991; 9(4-5):189-96. PubMed ID: 1743622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide. Patient care management.
    Lynch MP; Ruland T
    Cancer Nurs; 1993 Oct; 16(5):362-5. PubMed ID: 8261384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.